Literature DB >> 24141733

Myelin damage due to local quantitative abnormalities in normal prion levels: evidence from subacute combined degeneration and multiple sclerosis.

Giuseppe Scalabrino1, Daniela Veber.   

Abstract

Cobalamin (Cbl) deficiency causes an imbalance in some cytokines and growth factors in the central nervous system and peripheral nervous system (PNS) of the rat, and in the serum and cerebrospinal fluid (CSF) of adult Cbl-deficient (Cbl-D) patients. It is conceivable that this imbalance triggers subsequent cellular events. We hypothesized that an imbalance in normal prion (PrP(C)) levels and/or synthesis might be involved in the pathogenesis of Cbl-D neuropathy, and demonstrated that: (1) Cbl deficiency induces excess PrP(C) in rat spinal cord (SC) and PNS, concomitantly with myelin damage and PNS electrophysiological abnormalities; (2) the SC increase is mediated by a local Cbl deficiency-induced excess of tumor necrosis factor-α; (3) myelinotrophic Cbl and epidermal growth factor upregulate PrP(C)-mRNA levels in rat SC; (4) treatment with anti-PrP(C) octapeptide repeat region antibodies normalizes the ultrastructure of the Cbl-D rat SC and PNS myelins, and the PNS electrophysiological abnormalities, without modifying their Cbl-D status; (5) PrP(C) administration to otherwise normal rats causes SC and PNS myelin lesions and PNS electrophysiological abnormalities, similar to those of Cbl-D neuropathy; (6) CSF and serum PrP(C) concentrations in Cbl-D patients are significantly higher than in controls; and (7) these concentrations significantly correlate with their CSF and serum Cbl concentrations. CSF PrP(C) concentrations are significantly lower in patients with multiple sclerosis (MS) than neurological controls, but serum PrP(C) concentrations in patients with non-Cbl-D anemias and CSF PrP(C) concentrations in patients with non-myelin-damaging neurological diseases are normal.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24141733     DOI: 10.1007/s00415-013-7152-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  97 in total

1.  Epidermal growth factor promotes oligodendrocyte process formation and regrowth after injury.

Authors:  Pamela E Knapp; Mary H Adams
Journal:  Exp Cell Res       Date:  2004-06-10       Impact factor: 3.905

Review 2.  Cytokines in multiple sclerosis: from bench to bedside.

Authors:  Jaime Imitola; Tanuja Chitnis; Samia J Khoury
Journal:  Pharmacol Ther       Date:  2005-01-11       Impact factor: 12.310

Review 3.  Astrocyte dysfunction in neurological disorders: a molecular perspective.

Authors:  Gerald Seifert; Karl Schilling; Christian Steinhäuser
Journal:  Nat Rev Neurosci       Date:  2006-03       Impact factor: 34.870

Review 4.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

5.  Cobalamin (vitamin B(12)) regulation of PrP(C), PrP(C)-mRNA and copper levels in rat central nervous system.

Authors:  Giuseppe Scalabrino; Daniela Veber; Elena Mutti; Alberto Calligaro; Silvano Milani; Giovanni Tredici
Journal:  Exp Neurol       Date:  2011-11-12       Impact factor: 5.330

6.  Enhanced expression of cellular prion protein gene by insulin or nerve growth factor in immortalized mouse neuronal precursor cell lines.

Authors:  C Kuwahara; A Kubosaki; T Nishimura; Y Nasu; Y Nakamura; K Saeki; Y Matsumoto; T Onodera
Journal:  Biochem Biophys Res Commun       Date:  2000-02-24       Impact factor: 3.575

7.  Increased levels of the CD40:CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathy.

Authors:  Daniela Veber; Elena Mutti; Enrico Galmozzi; Sabrina Cedrola; Stefania Galbiati; Alberto Morabito; Giovanni Tredici; Caterina A La Porta; Giuseppe Scalabrino
Journal:  J Neuroimmunol       Date:  2006-05-22       Impact factor: 3.478

8.  Cytokines, prostaglandins and lipocortin-1 are present in the brains of scrapie-infected mice.

Authors:  A E Williams; A M van Dam; W K Man-A-Hing; F Berkenbosch; P Eikelenboom; H Fraser
Journal:  Brain Res       Date:  1994-08-22       Impact factor: 3.252

Review 9.  Prion diseases: from protein to cell pathology.

Authors:  Gabor G Kovacs; Herbert Budka
Journal:  Am J Pathol       Date:  2008-02-02       Impact factor: 4.307

Review 10.  Genetic and epigenetic contributions to human nutrition and health: managing genome-diet interactions.

Authors:  Patrick J Stover; Marie A Caudill
Journal:  J Am Diet Assoc       Date:  2008-09
View more
  2 in total

Review 1.  Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Authors:  Giuseppe Scalabrino
Journal:  Biomedicines       Date:  2022-03-30

2.  Hereditary defect of cobalamin metabolism with adolescence onset resembling multiple sclerosis: 41-year follow up in two cases.

Authors:  Jeremias Motte; Janina Kneiphof; Katrin Straßburger-Krogias; Kalliopi Pitarokoili; Anna Lena Fisse; Ludwig Kappos; Ralf Gold
Journal:  Ther Adv Neurol Disord       Date:  2019-08-24       Impact factor: 6.570

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.